ZYBERNO
Stock Report
Updated Aug 22, 2026

Jin Medical International Ltd. (ZJYL)

Healthcare • NASDAQ

$3.04

Professional Investment Analysis

ZYBERNO SCORE
Is it a great business? Is it getting better?
21.0/100
POOR BUSINESS
Jin Medical International Ltd. (ZJYL) scores 21/100 — concerning metrics indicating significant structural or financial risks.
📊 How is the Zyberno Score calculated? +
VALUATION SIGNAL
N/A (Requires more data)
Requires fair value calculation and current price data
💰 How is Margin of Safety calculated? +
📈 How is Brina Gap calculated? +

Critical Financial Health Indicators

Return on Equity (Profitability):CRITICAL (0.0%)
Debt-to-Equity (Solvency Risk):EXCELLENT (0.00x)
Operating Margin (Operational Efficiency):CRITICAL (0.0%)
Return on Capital (Capital Efficiency):CRITICAL (1.3%)
📊 Valuation Trilogy
Three interconnected metrics for complete valuation analysis
Click any metric for full methodology and detailed analysis
Zyberno's Verdict

Jin Medical International Ltd. (ZJYL) stock report — Zyberno Score 21/100 (POOR BUSINESS). Full financial analysis on Zyberno.

DIVISION I: EXECUTIVE SUMMARY
A. Market Valuation

Market Price & Capitalization (2)

Current Price:3.04
Market Cap:$25.46M

Valuation Multiples (3)

P/B Ratio:0.86x
P/S Ratio:1.23x
Peg Ratio:-999.00x

Enterprise Metrics (2)

Enterprise Value:$36.91M
Ev Ebitda Ratio:44.71x

Price Action & Momentum (1)

% of 52-Week High:17.7%
B. Profitability Assessment

Margin Analysis (1)

Ebitda Margin:4.0%

Yield Metrics (2)

Earnings Yield:-$999.00
Dividend Yield:0.0%
C. Log-Linear Regression Growth Trends
D. Financial Stability

Liquidity Ratios (3)

Current Ratio:1.86x
Quick Ratio:1.65x
Cash Ratio:0.31x

Leverage Analysis (3)

Debt To Equity Ttm:0.00x
Debt-to-Equity Ratio:0.00x
Debt To Ebitda:22.90x

Coverage Ratios (1)

Times Interest Earned:-999.00

Capital Structure (4)

Working Capital:20,347,322.00
Cash And Cash Equivalents:7,461,630.00
Long Term Debt:$72.65K
Net Debt:$11.45M
DIVISION II: FINANCIAL STATEMENTS ANALYSIS
A. Income Statement Analysis

Revenue Components (2)

$20.69M
Cost Of Revenue Ttm:$14.44M

Profitability Breakdown (2)

$6.24M$608.18K

Bottom Line Performance (3)

$1.19M
Income Before Tax:$1.60M
Ebitda Ttm:825,589.00

Operating Expenses (5)

Operating Expenses:5,436,351.00
R And D Expense:1,557,703.00
Sga Expense:2,533,438.00
Income Tax Expense:$214.57K
Interest Expense:0.00

Expense Ratios (3)

R And D To Revenue Percentage:7.5%
Sga To Revenue Percentage:12.2%
Ebitda Margin:4.0%
B. Balance Sheet Analysis

Asset Composition (5)

Total Assets:$53.37M
Current Assets:$44.14M
Ppe Net:7,895,385.00
Goodwill:0.00
Intangible Assets:$1.10M

Liability Structure (4)

Total Liabilities:23,795,891.00
Current Liabilities:23,795,891.00
Long Term Debt:$72.65K
Short Term Debt:$18.84M

Equity & Capital (3)

Equity:$29.57M
Retained Earnings:$20.94M
Common Stock:1,000,000,000.00

Working Capital Items (3)

Accounts Receivable:5,807,386.00
Inventory:4,923,164.00
Accounts Payable:3,256,624.00

Special Items (2)

Contract Liabilities:495,357.00
Stock Based Compensation:0.00
C. Cash Flow Analysis

Operating Activities (2)

$2.90M-$3.73M

Investment Activities (1)

Investing Cash Flow:-$10.79M

Financing Activities (3)

Financing Cash Flow:$7.35M
Dividends Paid Ttm:0.00
Stock Repurchase:0.00

Capital Transactions (3)

Common Stock Issuance:311,995.00
Long Term Debt Issuance:$0.00
Long Term Debt Repayments:$0.00

Non-Cash Items (1)

Depreciation Amortization Ttm:217,407.00
DIVISION III: OPERATIONAL METRICS
A. Per Share Analysis

Earnings Per Share (1)

Earnings Per Share Ttm:$0.14

Revenue & Cash Per Share (2)

Sales Per Share Ttm:2.47
Operating Cash Flow Per Share:$0.35

Book Value & Capital (2)

Book Value Per Share:$3.53
Cash Per Share:0.89

Dividend Policy (1)

Dividend Payout Ratio:-999.00x
B. Operational Efficiency

Asset Utilization (2)

Asset Turnover Ttm:0.39x
Working Capital Turnover Ttm:1.02x

Receivables Management (2)

Receivables Turnover Ttm:3.56x
Days Sales Outstanding Ttm:102.46

Inventory Management (2)

Inventory Turnover Ttm:2.93x
Days Inventory Outstanding Ttm:124.40

Payables & Cash Cycle (2)

Days Payable Outstanding:82.29
Cash Conversion Cycle:144.58
C. Quality & Risk Metrics

Financial Quality Scores (2)

Financial Strength Score:100.00
Quality Score:100.00

Market Metrics (2)

Beta:0.00x
Volatility Category:unknown
DIVISION IV: INVESTMENT ANALYSIS
A. Value Investment Framework
B. Log-Linear Regression Growth Analysis
C. Company Profile & Context

Corporate Information (6)

Symbol:ZJYL
Company Name:Jin Medical International Ltd.
Sector:Healthcare
Industry:Medical Devices
Exchange:NASDAQ
Country:China

Market Classification (3)

Market Cap Category:N/A
Price Category:low
Volume Category:N/A

Share Structure (3)

Shares Outstanding:8.38M
Shares Outstanding Basic:156.55M
Shares Outstanding Diluted:156.55M

Data Processing Info (3)

Processing Version:v3.0
Last Updated:2026-08-22 21:32:45 UTC
Data Timestamp:2026-08-21T07:29:56.326418
Scroll to Top